
Hinge Health
(NYSE) HNGE
Hinge Health Financials at a Glance
Market Cap
$4.87B
Revenue (TTM)
$646.34M
Net Income (TTM)
-$510.27M
EPS (TTM)
-$6.69
P/E Ratio
-9.42
Dividend
$0.00
Beta (Volatility)
0.16 (Low)
Dividend
$0.00
Beta (Volatility)
0.16 (Low)
Price
$63.49
Volume
176,005
Open
$63.00
Price
$63.49
Volume
176,005
Open
$63.00
Previous Close
$63.49
Daily Range
$63.00 - $66.55
52-Week Range
$30.08 - $66.55
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.16 (Low)
Price
$63.49
Volume
176,005
Open
$63.00
Previous Close
$63.49
Daily Range
$63.00 - $66.55
52-Week Range
$30.08 - $66.55
Estimated Earnings Date
Aug 4, 2026
HNGE News


Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hinge Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
143
CEO
Daniel Perez, PhD
Website
www.hingehealth.comHeadquarters
San Francisco, CA 94105, US
HNGE Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-82%
Net Income Margin
-79%
Return on Equity
-137%
Return on Capital
-2%
Return on Assets
-70%
Earnings Yield
-10.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.87B
Shares Outstanding
77.38M
Volume
176.00K
Avg. Volume
1.26M
Financials (TTM)
Gross Profit
$469.30M
Operating Income
-$546.37M
EBITDA
-$535.89M
Operating Cash Flow
$171.44M
Capital Expenditure
-$708.00K
Free Cash Flow
$170.73M
Cash & ST Invst.
$363.86M
Total Debt
$8.04M
Hinge Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$182.31M
+47.2%
Gross Profit
$154.23M
+53.9%
Gross Margin
84.60%
N/A
Market Cap
$4.87B
N/A
Market Cap/Employee
$3.22M
N/A
Employees
1,514
N/A
Net Income
$35.13M
-71.0%
EBITDA
$32.07M
+135.1%
Quarterly Fundamentals
Net Cash
$310.34M
-32.6%
Accounts Receivable
$114.92M
+51.4%
Inventory
$14.17M
+10.8%
Long Term Debt
$2.74M
-56.1%
Short Term Debt
$4.23M
+8.6%
Return on Assets
-70.02%
N/A
Return on Invested Capital
-1.68%
N/A
Free Cash Flow
$43.00M
+931.7%
Operating Cash Flow
$43.08M
+774.8%

